PAO Group, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- James C. DiPrima
- Full Time Employees
- 7
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 1190 Cleveland Road Sandusky OH United States of America 44870
- IPO Date
- Sep 8, 2009
- Website
- pao.group
- Similar Companies
- Business
- PAO Group, Inc. (OTC: PAOG) operates as a publicly traded holding company focused on alternative patient care treatments and diversified services; through its subsidiaries, the company engages in the development, sale, and distribution of premium medical cannabis products including CBD nutraceuticals such as RelaxRX CBD, RX branded lines, pet products, and pharmaceutical research pipelines for chronic, terminal, and women's health conditions; it also offers pain management, massage therapy, nutritional counseling, and hormone replacement therapies. Founded originally as Elite Field Service, Inc. in Nevada on June 23, 2003, renamed PAO Group, Inc. in 2017, and re-domiciled in Wyoming in 2020, the company maintains principal operations from Omaha, Nebraska, with historical headquarters references in Sandusky, Ohio, targeting patients in the United States across healthcare sectors like medical care facilities. In recent developments, PAO Group acquired 100% membership interest in Law 90, LLC, a Nevada-based legal services firm, on August 26, 2025, via share purchase agreement, integrating its management team including Founder James Scramm, appointing Schramm as new CEO in September 2025 with former CEO James DiPrima transitioning to CFO, and considering a name change to expand into nationwide legal services while accessing capital markets.
PAO Group, Inc. Announces Rescission of Agreement and Departure of CEO James Schramm
LAW90 Launches Revolutionary AI Positioning Program, Expands Into Texas Market, and Announces National Hiring for 2026
PAO Group Inc Acquires Law 90 LLC, Inc. Including its Law 90 Products
Astellas Announces Second Annual Patient Advocacy Organization (PAO) Action Week™ To Empower Patients and Caregivers
PURA and PAOG CBD Nutraceutical Collaboration Highlighted In 420 Update Tomorrow
PURA and PAOG On Track To Launch CBD Product Line For $40 Billion Women's Health Market
PURA and PAOG To Launch CBD Product Line Next Month For $40 Billion Women's Health Market
PURA and PAOG Plan Sneak Peek Of CBD Nutraceutical Product Line For $17 Billion Market Opportunity
PURA and PAOG Plan Joint CBD Nutraceutical Product Line Launch Next Month
Why Russian Stock Mechel PAO Soared Today
PURA and PAOG Announce CBD IP Deal In Conjunction With New CBD Infused Product Developments
PURA and PAOG Confirm CBD IP Deal Schedule To Close Friday
PURA and PAOG Look To Tissue Culture Technology For Pharma Cannabis Cultivation
PURA and PAOG Partner With UCASU in Cannabis Real Estate Deal
PAOG Stock: Why The Price Increased This Week
PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential
PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential
PAOG Introduces RelaxRX CBD Targeting $100 Billion Sleep Aid
PAOG Confirms Monday Marketing Launch Of First CBD Product Targeting $100 Billion Market
PAOG Confirms Monday Marketing Launch Of First CBD Product Targeting $100 Billion Market